Armand Cognetta

Founder — Armand completed his PhD in Chemical Biology at the Scripps Research Institute under the supervision of Dr. Benjamin F. Cravatt. There he co-authored 19 scientific publications in prestigious journals such as Cell, Nature, and Science, as well as multiple patents, including a portion of the foundational IP for Abide Therapeutics (acq. Lundbeck) and Vividion Therapeutics (acq. Bayer). Prior to founding GP he was an early employee at the Flagship Pioneering start-up Inzen Tx (now Sonata).

Details

linkedin url: https://www.linkedin.com/in/armandcognetta/
twitter url: https://twitter.com/armandcognetta

founded → company1

General Proximity

previously worked at → company1

Inzen Tx